Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
机构:[1]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.[2]Hebei Yanda Lu Daopei Hospital, Langfang, Hebei & Beijing Lu Daopei Hospital, Beijing, China.[3]The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Disease, Soochow, China.[4]The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.浙江大学医学院附属第一医院[5]State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.[6]Chinese PLA General Hospital, Beijing, China.[7]The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.[8]Xinqiao Hospital of Army Medical University, Chongqing, China.[9]Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.河南省肿瘤医院[10]Fujian Medical University Union Hospital, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fuzhou, China.[11]West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[12]The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.[13]Nanfang Hospital, Guangzhou, China.[14]Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.华中科技大学同济医学院附属协和医院[15]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.华中科技大学同济医学院附属同济医院[16]Xiangya Hospital, Central South University, Changsha, Hunan, China.[17]Nanfang-Chunfu Children's Institute of Hematology, Taixin Hospital, Dongguan, China.[18]Shanghai Institute of Hematology, Ruijn Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.[19]Shenzhen Children's Hospital, Shenzhen, Guangdong, China.深圳市儿童医院深圳医学信息中心[20]The First Affiliated Hospital of Guangxi Medical University, Nanning, China.[21]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. xjhrm@medmail.com.cn.
第一作者机构:[1]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
推荐引用方式(GB/T 7714):
Xu Lan-Ping,Lu Pei-Hua,Wu De-Pei,et al.Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group[J].Bone Marrow Transplantation.2024,doi:10.1038/s41409-024-02438-5.
APA:
Xu Lan-Ping,Lu Pei-Hua,Wu De-Pei,Huang He,Jiang Er-Lie...&.(2024).Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.Bone Marrow Transplantation,,
MLA:
Xu Lan-Ping,et al."Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group".Bone Marrow Transplantation .(2024)